Study Links Female Infertility to Future Cardiovascular Problems
Women who experience infertility are more likely to develop heart and blood vessel conditions later in life, with younger women and those who undergo fertility treatments at a greater risk. The findings, presented at the first Joint Congress between the European Society of Paediatric Endocrinology (ESPE) and the European Society of Endocrinology (ESE), highlight the importance of considering a woman’s reproductive history when assessing her long-term heart health.
Approximately one in every six people of reproductive age worldwide is estimated to experience infertility in their lifetime. Treatment of infertility often involves in-vitro fertilisation (IVF) and other types of assisted reproductive technology (ART).
In this study, looked at 21 studies, involving 178,828 women with infertility and 3,398,781 women without fertility issues, that associated female infertility with cardiovascular disease later in life. The researchers found that women with infertility have a 14% increased risk of developing conditions affecting the heart or blood vessels, a 17% increased risk of heart disease and a 16% increased risk of a stroke when compared to women without an infertility history. In addition, the risk of cardiovascular disease increased by 20% in younger women with infertility, especially those under 40, and by 4% in women who underwent assisted reproductive technology treatments.
“This is the largest meta-analysis to not only examine the potential link between a history of infertility in women and cardiovascular risk but also the impact of assisted reproductive technologies on their likelihood of developing future cardiovascular events,” said lead researcher Dr Elena Armeni. “By gathering data from many studies, our work adds strong evidence to a growing field and suggests that infertility could be an early warning sign for future heart health issues.”
Dr Armeni added: “Recognising infertility as a potential early marker for cardiovascular disease could help doctors identify women who may need closer monitoring or preventive strategies earlier in life. It also raises important questions about the long-term effects of fertility treatments like assisted reproductive technology (ART) treatments.”
Reference: https://espe-ese-congress2025.org/wp content/uploads/2025/05/press_release_Armeni-final.pdf
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.